Form 4: BIOLIFE SOLUTIONS CTO Sells Shares for Tax Obligations

BIOLIFE SOLUTIONS Chief Technology Officer, Sean Werner, sold 111 shares of common stock to cover tax withholding obligations.

Summary

• Sean Werner, Chief Technology Officer of BIOLIFE SOLUTIONS INC (BLFS), reported a sale of common stock.
• The transaction involved the disposition of 111 shares of common stock.
• The shares were sold at a price of $25.44 per share.
• Following this transaction, Sean Werner beneficially owns 26,384 shares of common stock.
• The sale was executed on August 26, 2025, pursuant to a Rule 10b5-1(c) trading plan.
• The 10b5-1 plan was adopted by the reporting person effective February 24, 2022.
• The purpose of the sale was to satisfy tax withholding obligations related to the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, pre-planned sale for tax withholding purposes, which is neutral in terms of its implications for the company's operational performance or the insider's confidence in the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This is a routine insider transaction for tax purposes and does not provide specific insights into broader industry trends or competitive landscape for BIOLIFE SOLUTIONS.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a small, pre-planned, tax-related sale by an insider, not indicative of a change in company fundamentals or management's long-term view.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned sale of a small number of shares by the Chief Technology Officer to cover tax withholding obligations. Such transactions, executed under a Rule 10b5-1 plan, are not typically indicative of a change in the insider's sentiment towards the company or its future prospects. Therefore, this filing alone does not warrant a change in investment recommendation; a 'hold' stance is appropriate as it provides no new material information affecting the company's fundamentals.

Keywords

BIOLIFE SOLUTIONS, BLFS, Sean Werner, Chief Technology Officer, Insider Sale, Form 4, 10b5-1 Plan, Stock Transaction, Tax Withholding